INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
INJECTION
INDUSTRIALISATION
Mark Foster
Oliver Design
WHEN SECONDARY PACKAGING IS A PRIMARY CONCERN
Mark Foster discusses the challenges to optimising primary and secondary packaging for parenteral drug delivery devices, including higher level challenges from the patient perspective, as well as how these challenges present opportunities for device developers to stand out in the market.
WEARABLES
Christian Esser Wiesemann
Ypsomed
YPSODOSE – THE CLINIC-READY 10 ML PATCH INJECTOR
Christian Esser Wiesemann provides the latest insights into the prefilled and pre-assembled YpsoDose patch injector, which is now available for clinical trials.
WEARABLES
Dr Mehul Desai
Enable Injections
A NEW FRONTIER: SELF-ADMINISTRATION OF LYOPHILISED, LARGE-VOLUME SUBCUTANEOUS BIOLOGICS
Mehul Desai and Daniel Waites discuss the pros and cons of lyophilisation for biologic injectable drugs, and how Enable Injections’ enFuse device can provide an answer to the challenges of self-injection of large-volume and lyophilised biologics.
WEARABLES
Heiko Haller
ZwickRoell
PRODUCT SHOWCASE: COMPLETE SYSTEM FOR STANDARD-COMPLIANT TESTING OF WEARABLE INJECTORS
Specifically tailored to on-body delivery systems (OBDSs) / wearable injectors, ZwickRoell showcases its customised, comprehensive solution for performing functional tests in accordance with the ISO 11608-6 standard.
SUSTAINABILITY
Maike Wolf
Gerresheimer
SUSTAINABLE DESIGN OF A DRUG DELIVERY DEVICE FOR BIOPHARMACEUTICALS
Maike Wolf and Marie Stockton discuss how sustainability is a fundamental strategic priority for Gerresheimer. They also highlight how eco-design principles have been applied to the development of an on-body injector for subcutaneous delivery of biopharmaceuticals.
WEARABLES
Thomas Mayer
Sonceboz
COMPARISON OF MECHATRONIC VS MECHANICAL WEARABLE DRUG DELIVERY SYSTEMS
Thomas Mayer, Nicolas Bailo and Martin Liniger highlight some of the key challenges that mechanical and mechatronic drug delivery systems must overcome when delivering large volumes of biologics subcutaneously and explain the solutions that Sonceboz has considered during the development process of the company’s large-volume injector.
WEARABLES
Dr Iris Schnitzler
LTS
EXTENDING PATIENT-FRIENDLY DRUG DELIVERY TO HIGH-VOLUME WEARABLE DEVICES
Iris Schnitzler discusses the benefits of on-body delivery systems, including the flexibility and convenience they bring to patients managing chronic conditions, and how the Sorrel platform overcomes some of the inherent complexities and challenges of developing such a device. Dr Schnitzler then goes on to speak with Bas van Buijtenen and Andrei Yosef about the Sorrel platform and how its integration within LTS supports the company’s fundamental objectives of enabling partners and empowering patients.
WEARABLES
Dr Adam Stops
Stevanato Group
THE VERTIVA™ ON-BODY DELIVERY SYSTEM: EXPANDING OPPORTUNITIES IN HOME-BASED CARE
Adam Stops introduces Vertiva™, Stevanato Group’s next-generation on-body delivery system platform, and discusses how it meets the needs of pharma companies looking to deliver large-volume doses in a patient-centric manner.
WEARABLES
Cecile Gross
Nemera
CHRONIC PATIENTS AT THE CENTRE OF LARGE-VOLUME SC DELIVERY WITH A SUSTAINABLE ON-BODY INJECTOR
Cécile Gross and Mark Tunkel discuss the role of patient-centricity in the development of Nemera’s sustainable on-body injector platform.
CONNECTIVITY
Jimmy Fan
CC Bio
Technology Showcase: CCBio’s Felice Dose – Simplifying Subcutaneous Infusion
CCBio showcases Felice Dose, a revolutionary on-body injector (OBI) designed to address the challenges of traditional IV injections and SC drug administration.
EXPERT VIEW
Roger Bohannan
INJECTING INNOVATIVE SOLUTIONS INTO CONNECTED DELIVERY DEVICES
Roger Bohannan discusses the capabilities and design challenges of connected drug delivery devices.
EXPERT VIEW
Dave Beckstoffer
INCORPORATING MOTION DESIGN AT EARLY STAGES OF WEARABLE INJECTOR DEVELOPMENT
Dave Beckstoffer discusses the often overlooked importance of including motion system design considerations from the very earliest stages of wearable injector development, and how doing so can reduce costs, shorten timelines and improve patient outcomes.
EXPERT VIEW
Matt Parker
DIRECTIONS FOR WEARABLE ON-BODY INJECTOR SYSTEMS AND BEYOND
Matt Parker, Karthik Chellappan and David Cottenden discuss the current state of play for large-volume injection and look into the challenges that on-body delivery systems currently in development will need to overcome to find success in a changing marketplace.
EXPERT VIEW
Malcolm Boyd
WOULD YOU LIKE TO GO LARGE? KEY CONSIDERATIONS FOR LARGE-VOLUME INJECTORS
Malcolm Boyd discusses the factors that need to be considered early in the development of large-volume injectors, which will have a major influence on the performance, usability and cost of a device.
EXPERT VIEW
Thomas James
REUSABLE WEARABLE INJECTORS: LESSONS FROM IN VITRO DIAGNOSTICS
Thomas James explores how insights from the development of successful in vitro diagnostic instruments can help guide the evolution of wearable injectors.
WEARABLES
Beth McBride DiLauri
BD (Becton Dickinson & Company)
BD INNOVATION FOR SUBCUTANEOUS DELIVERY OF LARGE-VOLUME COMPLEX BIOLOGICS
Beth McBride DiLauri summarises the results of a clinical study on the BD Libertas™ Wearable Injector. The results position the device as a viable alternative to traditional intravenous administration.
INDUSTRIALISATION
Dr Ben Knappett
Particle Works
HIGH-THROUGHPUT SCREENING TO ACCELERATE NANOMEDICINE DISCOVERY
Ben Knappett discusses how the successful combination of microfluidics with automation can provide rapid and cost-effective high-throughput lipid nanoparticle technology formulation screening, and how this approach could play a significant role in advancing the development of new nanotherapies.
INDUSTRIALISATION
Jennifer Riter
West Pharmaceutical Services
SUCCESSFUL INDUSTRIALISATION REQUIRES SOLID FOUNDATIONS
Jennifer Riter and Victoria Morgan discuss the importance of choosing the right containment system at the start for successful industrialisation of an injectable drug product.
INTERVIEW
Julien Martins
Paragon Medical
Interview with Julien Martins & David Philbrick
Julien Martins and David Philbrick talk exclusively with ONdrugDelivery's Guy Furness. They discuss a wide range of topics, including the services Paragon Medical provides the drug delivery industry, its wider business operations, the company’s expanded facilities in the US and Europe, and its new Advanced Surgical Innovation Center.
INDUSTRIALISATION
Mads Keinicke Hansen
Stevanato Group
HOW A FLEXIBLE APPROACH TO AUTOINJECTOR ASSEMBLY EQUIPMENT CAN DELIVER A COMPETITIVE ADVANTAGE
Mads Keinicke Hansen presents an overview of the company’s Standard Autoinjector Assembly Machine platform, providing an in-depth examination of its key features and advantages to illustrate how it is transforming autoinjector assembly processes in the pharmaceutical industry.
INDUSTRIALISATION
Yacine Haddadi
BD (Becton Dickinson & Company)
RFID-BASED UNIT-LEVEL TRACEABILITY: COULD IT BE THE KEY TO OPERATIONAL EXCELLENCE FOR FILL-FINISH LINES?
Yacine Haddadi and Herve Soukiassian look at how the company’s track & trace model can help manufacturers improve their fill-finish operations.
CONNECTIVITY
Ali Badiei
Gerresheimer
DIGITAL TWIN IN THE PHARMACEUTICAL SUPPLY CHAIN
Gerresheimer’s Ali Badiei explains the role of digital twin technology and its integration into the pharmaceutical supply chain, highlighting an innovative approach to ensuring drug identity and quality.
CONNECTIVITY
Dr Kate Hudson-Farmer
PA Consulting
REIMAGINING AUTOINJECTOR CONNECTIVITY
Kate Hudson-Farmer and Simon Hall discuss a new smartphone-based connectivity solution for autoinjectors that requires no additional hardware and works with most autoinjectors and smartphones.
CONNECTIVITY
Ventsislav Dobrev
Ypsomed
Real-World Evidence in the Age of Digital Health – Unlocking Value for Pharmaceutical Companies
Ventsislav Dobrev, Philippe Müller and Rafael Weiler explore how real-world evidence in the age of digital health can help unlock value for pharmaceutical companies.
Prev
1
…
11
12
13
14
15
…
44
Next
Top
